Published in Cancer Weekly, August 10th, 1998
Squalamine, previously shown to have antibiotic and anti-cancer activity, inhibited the growth of brain cancers called gliomas implanted in the flanks of rats by disabling blood vessel growth, or angiogenesis, reported the authors of the studies, published in the July 1, 1998, issue of the journal Cancer Research.
"Our results suggest that squalamine may be well suited for humans in the treatment of brain tumors and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.